Survival in NSCLC Resection Can be Prolonged With Help Of Statins

by Rukmani Krishna on  October 30, 2012 at 11:38 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Overall survival and the risk of recurrence can be reduced by patients who have undergone resection for non-small cell lung cancer (NSCLC) by taking statins.
 Survival in NSCLC Resection Can be Prolonged With Help Of Statins
Survival in NSCLC Resection Can be Prolonged With Help Of Statins

Researchers from Northwestern University Feinberg School of Medicine, Chicago, and Penn State Hershey Cancer Institute followed 803 patients who underwent resection for NSCLC, of which 315 were using statins. Results showed that statin use was associated with a significantly lower local recurrence rate and significantly higher overall survival compared with non-statin users.

Researchers conclude that prospective studies are needed to assess the role of statin therapy as an adjunct to current multimodality regimens. This study was presented during CHEST 2012, the annual meeting of the American College of Chest Physicians, held October 20 - 25, in Atlanta, Georgia.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Cholesterol Cholesterol - The Enigma Chemical Statins 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive